LAB

Standard Biotools INC

-$114.7M

Net Activity

Institutions Holding

173

Popularity Rank

#3244

Avg Weight

0.21%

Total Value

$347.0M

Ownership Trend

173 institutions currently hold LAB, with 70 net buyers and 81 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

81

Net Buying Institutions

70

Key Holders

View all 173 holding institutions

Quarterly Activity

Recent Activity

+$90.6M

Total Buy Value

$134.1M

Total Sell Value

New buy18
Trim55
Add52
Sold out26

70

Net Buyers

81

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding STANDARD BIOTOOLS INC (LAB)?
Major stakeholders currently include Casdin Capital, LLC ($81.6M), Viking Global Investors LP ($53.9M), Mak Capital One LLC ($24.1M). Based on the latest 13F filings, there are a total of 173 tracked investment funds and institutions maintaining positions in LAB.
What is the overall institutional sentiment toward LAB recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $114.7M, driven by 70 managers accumulating shares while 81 reduced their exposure.
Which institutions have been selling or reducing their LAB positions?
In the latest period, 55 funds trimmed their holdings, and 26 managers completely exited their positions. The aggregate reported sell value was $134.1M.
Are there any notable investors adding LAB to their portfolios?
Yes, buying activity remains notable. 18 institutions opened new positions in {ticker}, and 52 existing holders added to their shares. The total reported buy value for the quarter amounted to $90.6M.

Related Stocks